MyTACTIC: Activity of targeted therapy in patients (pts) with advanced solid tumors harboring specific biomarkers

被引：0
|
作者：
Schwartzberg, Lee S.
Spigel, David R.
VanderWalde, Ari
Zuniga, Richard Michael
Hong, Jason
Szado, Tania
Yoo, Bongin
Passler, Luke
Wang, Yong
Darbonne, Walter C.
Daniel, Davey
机构：
[1] Renown Hlth Pennington Canc Inst, Reno, NV USA
[2] Sarah Cannon Res Inst, Nashville, TN USA
[3] West Canc Ctr & Res Inst, Clin Res, Germantown, TN USA
[4] OneOncol Inc, Nashville, TN USA
[5] Genentech Inc, US Med Affairs Oncol, South San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3100
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Targeted Therapy in Older Patients With Solid Tumors
    Kelly, Ciara M.
    Power, Derek G.
    Lichtman, Stuart M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (24) : 2635 - 2646
  • [2] Patupilone combined with carboplatin in patients (pts) with advanced solid tumors: preliminary safety and activity results
    Fracasso, P. M.
    Ravaud, A.
    Baggstrom, M. Q.
    LoRusso, P. M.
    Jones, D. V.
    Sguotti, C.
    Urban, P.
    Gao, B.
    Medioni, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] A phase I study of LXH254 in patients (pts) with advanced solid tumors harboring MAPK pathway alterations.
    Janku, Filip
    Iyer, Gopa
    Spreafico, Anna
    Yamamoto, Noboru
    Bang, Yung-Jue
    Elez, Elena
    De Jonge, Maja J.
    Groen, Harry J. M.
    Marme, Frederik
    Gollmer, Kathrin
    St-Pierre, Annie
    Melendez, Maritza
    Mais, Anna
    Nauwelaertsx, Heidi
    Nauwelaerts, Heidi
    Stammberger, Uz M.
    Dummer, Reinhard
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [4] Population pharmacokinetic modeling of tremelimumab in patients (pts) with advanced solid tumors
    Even, C.
    Goldberg, S. B.
    Siu, L. L.
    Planchard, D.
    Hwang, M.
    Chen, C. C-K.
    He, J.
    Song, X.
    Zhou, D.
    Doake, R.
    Krug, L.
    Peters, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1451 - S1452
  • [5] Phase I trial of imexon (IMX) in patients (pts) with advanced solid tumors
    Dragovich, T
    Mendelson, D
    Gordon, M
    Long, K
    Downhour, M
    Dorr, R
    Hersh, E
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 229S - 229S
  • [6] A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC).
    Grothey, Axel
    Howland, Michael
    Hubbard, Lloryn
    Szado, Tania
    McDonald, Anne
    Darbonne, Walter C.
    Levy, Jonathan
    Borden, Eucharia
    Spigel, David R.
    Vanderwalde, Ari M.
    Schwartzberg, Lee S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [7] Targeted Therapy for Advanced Thymic Tumors
    Rajan, Arun
    Giaccone, Giuseppe
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 : S361 - S364
  • [8] Larotrectinib A targeted therapy for solid tumors
    Mota-George, Gabriela
    Schneider, Susan M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2021, 25 (02) : 181 - 187
  • [9] WEEKLY TAXANES: TOLERABILITY PROFILE IN ELDERLY OR UNFIT PATIENTS (PTS) WITH ADVANCED SOLID TUMORS
    Carboni, Rita
    Maisano, Roberto
    Zavettieri, Maria
    Azzarello, Domenico
    Raffaele, Mario
    Mafodda, Antonino
    Mare, Marzia
    Del Medico, Pietro
    LaTorre, Francesco
    Nardi, Mario
    ANNALS OF ONCOLOGY, 2004, 15 : 44 - 44
  • [10] A phase I study of oral darinaparsin in patients (pts) with advanced solid tumors (AST).
    Camacho, Luis H.
    Senzer, Neil N.
    Harb, Wael A.
    Barrett, John A.
    Korth, Christopher Charles
    Astl, Dorothea
    Jac, Jaroslaw
    Youssoufian, Hagop
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345